The Department of Veterans Affairs, specifically the James A. Haley Veterans' Hospital, intends to award a sole source contract to Veteran Healthcare Supply Solutions (VHSS) for the provision of FDA-approved, brand-specific Biocartis PCR-based instrumentation and reagents. This procurement is essential for conducting critical genetic testing, including BRAF Mutation, EGFR Mutation, and Microsatellite Instability (MSI), which play a vital role in oncology diagnosis and treatment planning. VHSS is uniquely qualified for this contract as they are the sole authorized distributor designated by the Original Equipment Manufacturer, Biocartis, ensuring warranty and support for the equipment. Interested vendors who believe they can meet the specified requirements may submit capability statements by September 10, 2025, to the Contracting Officer, Marcus Lewis, at Marcus.Lewis2@va.gov.